Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy

Transfusion

Volumn 53, Issue 6, 2013, Pages 1309-1318

  Peterson, Julie A ^a   Kanack, Adam ^a   Nayak, Dhirendra ^a   Bougie, Daniel W ^a   McFarland, Janice G ^a   Curtis, Brian R ^a   Aster, Richard H ^a  

^a not available   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DRB3 ANTIGEN; HUMAN PLATELET ANTIGEN 1A; HUMAN PLATELET ANTIGEN 1A ANTIBODY; HUMAN PLATELET ANTIGEN 1B; IMMUNOGLOBULIN G; THROMBOCYTE ANTIBODY; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CELL DESTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; MALE; MOUSE; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEONATAL THROMBOCYTOPENIA; NONHUMAN; PATIENT REFERRAL; PREGNANCY; PREVALENCE; SEROLOGY; SURFACE PLASMON RESONANCE;

EID: 84878928924     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03903.x     Document Type: Article

References (32)

1. Williamson LM, Hackett G, Rennie J, Palmer CR, Maciver C, Hadfield R, Hughes D, Jobson S, Ouwehand WH,. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998; 92: 2280-7.
2. Kjeldsen-Kragh J, Killie MK, Tomter G, Golebiowska E, Randen I, Hauge R, Aune B, Øian P, Dahl LB, Pirhonen J, Lindeman R, Husby H, Haugen G, Grønn M, Skogen B, Husebekk A,. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 2007; 110: 833-9.
3. Dreyfus M, Kaplan C, Verdy E, Schlegel N, Durand-Zaleski I, Tchernia G,. Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group. Blood 1997; 89: 4402-6.
4. Mao C, Guo J, Chituwo BM,. Intraventricular haemorrhage and its prognosis, prevention and treatment in term infants. J Trop Pediatr 1999; 45: 237-40.
5. Bussel J,. Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. J Thromb Haemost 2009; 7 Suppl 1: 253-7.
6. Shulman NR, Aster RH, Pearson HA, Hiller MC,. Immunoreactions involving platelet. VI. Reactions of maternal isoantibodies responsible for neonatal purpura. Differentiation of a second platelet antigen system. J Clin Invest 1962; 41: 1059-69.
7. Kaplan C,. The role of the low-frequency antigens in neonatal alloimmune thrombocytopenia. ISBT Sci Ser 2007; 2: 106-10.
8. Peterson JA, Gitter ML, Kanack A, Curtis B, McFarland J, Bougie D, Aster R,. New low-frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia. Transfusion 2010; 50: 324-33.
9. Peterson JA, Pechauer SM, Gitter ML, Kanack A, Curtis BR, Reese J, Kamath VM, McFarland JG, Aster RH,. New platelet glycoprotein polymorphisms causing maternal immunization and neonatal alloimmune thrombocytopenia. Transfusion 2012; 52: 1117-24.
10. Kekomaki R, Raivio P, Kero P,. A new low-frequency platelet alloantigen, Vaa, on glycoprotein IIbIIIa associated with neonatal alloimmune thrombocytopenia. Transfus Med 1992; 2: 27-33.
11. Bertrand G, Jallu V, Saillant D, Kervran D, Martageix C, Kaplan C,. The new platelet alloantigen Cab a: a single point mutation Gln 716 His on the alpha 2 integrin. Transfusion 2009; 49: 2076-83.
12. Jallu V, Dusseaux M, Kaplan C,. A new Ser472Asn (Cab2[a+]) polymorphism localized within the alphaIIb "thigh" domain is involved in neonatal thrombocytopenia. Transfusion 2011; 51: 393-400.
13. Kroll H, Feldmann K, Zwingel C, Hoch J, Bald R, Bein G, Bayat B, Santoso S,. A new platelet alloantigen, Swi(a), located on glycoprotein Ia identified in a family with fetal and neonatal alloimmune thrombocytopenia. Transfusion 2011; 51: 1745-54.
14. Sachs UJ, Bakchoul T, Eva O, Giptner A, Bein G, Aster RH, Gitter M, Peterson J, Santoso S,. A point mutation in the EGF-4 domain of beta(3) integrin is responsible for the formation of the Sec(a) platelet alloantigen and affects receptor function. Thromb Haemost 2012; 107: 80-7.
15. Davoren A, Curtis BR, Aster RH, McFarland JG,. Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 2004; 44: 1220-5.
16. Curtis BR, McFarland JG,. Detection and identification of platelet antibodies and antigens in the clinical laboratory. Immunohematology 2009; 25: 125-35.
17. Mueller-Eckhardt C, Kayser W, Forster C, Mueller-Eckhardt G, Ringenberg C,. Improved assay for detection of platelet-specific PlA1 antibodies in neonatal alloimmune thrombocytopenia. Vox Sang 1982; 43: 76-81.
18. Socher I, Andrei-Selmer C, Bein G, Kroll H, Santoso S,. Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology. Transfusion 2009; 49: 943-52.
19. Bakchoul T, Kubiak S, Krautwurst A, Roderfeld M, Siebert HC, Bein G, Sachs UJ, Santoso S,. Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia. Transfusion 2011; 51: 2455-61.
20. Curtis BR, Edwards JT, Hessner MJ, Klein JP, Aster RH,. Blood group A and B antigens are strongly expressed on platelets of some individuals. Blood 2000; 96: 1574-81.
21. Ruan L, Pei B, Li Q,. Multicolor real-time polymerase chain reaction genotyping of six human platelet antigens using displacing probes. Transfusion 2007; 47: 1637-42.
22. Fitzgerald LA, Leung B, Phillips DR,. A method for purifying the platelet membrane glycoprotein IIb-IIIa complex. Anal Biochem 1985; 151: 169-77.
23. Pidard D, Montgomery RR, Bennett JS, Kunicki TJ,. Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb/IIIa complex, with intact platelets. J Biol Chem 1983; 258: 12582-6.
24. Bougie DW, Nayak D, Boylan B, Newman PJ, Aster RH,. Drug-dependent clearance of human platelets in the NOD/scid mouse by antibodies from patients with drug-induced immune thrombocytopenia. Blood 2010; 116: 3033-8.
25. Newman PJ, Aster R, Boylan B,. Human platelets circulating in mice: applications for interrogating platelet function and survival, the efficacy of antiplatelet therapeutics, and the molecular basis of platelet immunological disorders. J Thromb Haemost 2007; 5 Suppl 1: 305-9.
26. Braud V, Chevrier D, Cesbron A, Bignon JD, Kaplan C, Valentin N, Muller JY,. Susceptibility to alloimmunization to platelet HPA-1a antigen involves TAP1 polymorphism. Hum Immunol 1994; 41: 141-5.
27. L'Abbe D, Tremblay L, Filion M, Busque L, Goldman M, Décary F, Chartrand P,. Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201. Hum Immunol 1992; 34: 107-14.
28. Maslanka K, Yassai M, Gorski J,. Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia. J Clin Invest 1996; 98: 1802-8.
29. Rayment R, Kooij TW, Zhang W, Siebold C, Murphy MF, Allen D, Willcox N, Roberts DJ,. Evidence for the specificity for platelet HPA-1a alloepitope and the presenting HLA-DR52a of diverse antigen-specific helper T cell clones from alloimmunized mothers. J Immunol 2009; 183: 677-86.
30. Moulds MK,. Serological investigation and clinical significance of high-titer, low-avidity (HTLA) antibodies. Am J Med Technol 1981; 47: 789-95.
31. Rolih S,. A review: antibodies with high-titer, low-avidity characteristics. Immunohematology 1990; 6: 59-67.
32. Lee WM, Grindle K, Pappas T, Marshall DJ, Moser MJ, Beaty EL, Shult PA, Prudent JR, Gern JE,. High-throughput, sensitive, and accurate multiplex PCR-microsphere flow cytometry system for large-scale comprehensive detection of respiratory viruses. J Clin Microbiol 2007; 45: 2626-34.